Press Release Molecular Partners Announces Clinical Progress in Phase 2 TACTIC Combination Trial of MP0317 for Patients with Cholangiocarcinoma Jul 15
Press Release Molecular Partners Showcases Bispecific Radio-DARPins at Gordon Research Conference Jul 14